Skip to content

Comparing Oral and Nasal Methods of Giving Arsenicum Iodatum for Treating Allergic Rhinitis in Children

Comparative study of Oral and Olfaction routes of administration of Arsenicum iodatum in the treatment of Allergic Rhinitis among Paediatric age group - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/095225
Enrollment
40
Registered
2025-09-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

Intervention1: Arsenicum iodatum: Initial administration orally in 30 C potency , once in a day. Subsequent change in potency and dose will be based on assessing the improvement of the patient Total d

Sponsors

Post Graguate research funded by the institution
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Patient with history of allergic cause, symptoms of allergic rhinitis - Presence of symptoms as per Allergic Rhinitis and its Impact on Asthma classification - Informed consent to treatment.

Exclusion criteria

Exclusion criteria: - Patients who are not symptomatic to allergic rhinitis - Patients suffering from other severe systemic diseases

Design outcomes

Primary

MeasureTime frame
- Disappearance of symptoms will be noted - Comparison of improvement with oral and olfaction route of administration will be noted Timepoint: 3 months

Secondary

MeasureTime frame
Changes in the quality of life will be assessedTimepoint: 3 months

Countries

India

Contacts

Public ContactDr P R Sisir

Sarada Krishna Homoeopathic Medical College

hodpd@skhmc.org9443474941

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026